According to this latest study, the 2020 growth of Gabapentin will have significant change from previous year. By the most conservative estimates of global Gabapentin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1454.3 million in 2019. Over the next five years the Gabapentin market will register a 1.9% CAGR in terms of revenue, the global market size will reach US$ 1565.9 million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Capsule
Tablet
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Epilepsy
Neuropathic Pain
Restless Legs Syndrome
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Pfizer
Assertio Therapeutics
TEVA
Mylan
Arbor Pharma
Novartis
Apotex
Sun Pharmaceutical
Aurobindo Pharma
Intas
Amneal
Marksans Pharma
Glenmark
Alkem
Jiangsu Enhua
Jiangsu Hengrui
Sailike
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gabapentin Consumption 2016-2026
2.1.2 Gabapentin Consumption CAGR by Region
2.2 Gabapentin Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Gabapentin Sales by Type
2.3.1 Global Gabapentin Sales Market Share by Type (2016-2021)
2.3.2 Global Gabapentin Revenue and Market Share by Type (2016-2021)
2.3.3 Global Gabapentin Sale Price by Type (2016-2021)
2.4 Gabapentin Segment by Application
2.4.1 Epilepsy
2.4.2 Neuropathic Pain
2.4.3 Restless Legs Syndrome
2.4.4 Others
2.5 Gabapentin Sales by Application
2.5.1 Global Gabapentin Sale Market Share by Application (2016-2021)
2.5.2 Global Gabapentin Revenue and Market Share by Application (2016-2021)
2.5.3 Global Gabapentin Sale Price by Application (2016-2021)
3 Global Gabapentin by Company
3.1 Global Gabapentin Sales Market Share by Company
3.1.1 Global Gabapentin Sales by Company (2019-2021)
3.1.2 Global Gabapentin Sales Market Share by Company (2019-2021)
3.2 Global Gabapentin Revenue Market Share by Company
3.2.1 Global Gabapentin Revenue by Company (2019-2021)
3.2.2 Global Gabapentin Revenue Market Share by Company (2019-2021)
3.3 Global Gabapentin Sale Price by Company
3.4 Global Manufacturers Gabapentin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gabapentin Product Location Distribution
3.4.2 Players Gabapentin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Gabapentin by Region
4.1 Global Gabapentin by Region
4.1.1 Global Gabapentin Sales by Region
4.1.2 Global Gabapentin Revenue by Region
4.2 Americas Gabapentin Sales Growth
4.3 APAC Gabapentin Sales Growth
4.4 Europe Gabapentin Sales Growth
4.5 Middle East & Africa Gabapentin Sales Growth
5 Americas
5.1 Americas Gabapentin Sales by Country
5.1.1 Americas Gabapentin Sales by Country (2016-2021)
5.1.2 Americas Gabapentin Revenue by Country (2016-2021)
5.2 Americas Gabapentin Sales by Type
5.3 Americas Gabapentin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gabapentin Sales by Region
6.1.1 APAC Gabapentin Sales by Region (2016-2021)
6.1.2 APAC Gabapentin Revenue by Region (2016-2021)
6.2 APAC Gabapentin Sales by Type
6.3 APAC Gabapentin Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gabapentin by Country
7.1.1 Europe Gabapentin Sales by Country (2016-2021)
7.1.2 Europe Gabapentin Revenue by Country (2016-2021)
7.2 Europe Gabapentin Sales by Type
7.3 Europe Gabapentin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gabapentin by Country
8.1.1 Middle East & Africa Gabapentin Sales by Country (2016-2021)
8.1.2 Middle East & Africa Gabapentin Revenue by Country (2016-2021)
8.2 Middle East & Africa Gabapentin Sales by Type
8.3 Middle East & Africa Gabapentin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Gabapentin Distributors
10.3 Gabapentin Customer
11 Global Gabapentin Market Forecast
11.1 Global Gabapentin Forecast by Region
11.1.1 Global Gabapentin Forecast by Regions (2021-2026)
11.2.2 Global Gabapentin Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Gabapentin Forecast by Type
11.7 Global Gabapentin Forecast by Application
12 Key Players Analysis
12.1 Pfizer
12.1.1 Pfizer Pfizer Company Information
12.1.2 Pfizer Gabapentin Product Offered
12.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Assertio Therapeutics
12.2.1 Assertio Therapeutics Company Information
12.2.2 Assertio Therapeutics Gabapentin Product Offered
12.2.3 Assertio Therapeutics Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Assertio Therapeutics Main Business Overview
12.2.5 Assertio Therapeutics Latest Developments
12.3 TEVA
12.3.1 TEVA Company Information
12.3.2 TEVA Gabapentin Product Offered
12.3.3 TEVA Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 TEVA Main Business Overview
12.3.5 TEVA Latest Developments
12.4 Mylan
12.4.1 Mylan Company Information
12.4.2 Mylan Gabapentin Product Offered
12.4.3 Mylan Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Mylan Main Business Overview
12.4.5 Mylan Latest Developments
12.5 Arbor Pharma
12.5.1 Arbor Pharma Company Information
12.5.2 Arbor Pharma Gabapentin Product Offered
12.5.3 Arbor Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Arbor Pharma Main Business Overview
12.5.5 Arbor Pharma Latest Developments
12.6 Novartis
12.6.1 Novartis Company Information
12.6.2 Novartis Gabapentin Product Offered
12.6.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Novartis Main Business Overview
12.6.5 Novartis Latest Developments
12.7 Apotex
12.7.1 Apotex Company Information
12.7.2 Apotex Gabapentin Product Offered
12.7.3 Apotex Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Apotex Main Business Overview
12.7.5 Apotex Latest Developments
12.8 Sun Pharmaceutical
12.8.1 Sun Pharmaceutical Company Information
12.8.2 Sun Pharmaceutical Gabapentin Product Offered
12.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Sun Pharmaceutical Main Business Overview
12.8.5 Sun Pharmaceutical Latest Developments
12.9 Aurobindo Pharma
12.9.1 Aurobindo Pharma Company Information
12.9.2 Aurobindo Pharma Gabapentin Product Offered
12.9.3 Aurobindo Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Aurobindo Pharma Main Business Overview
12.9.5 Aurobindo Pharma Latest Developments
12.10 Intas
12.10.1 Intas Company Information
12.10.2 Intas Gabapentin Product Offered
12.10.3 Intas Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Intas Main Business Overview
12.10.5 Intas Latest Developments
12.11 Amneal
12.11.1 Amneal Company Information
12.11.2 Amneal Gabapentin Product Offered
12.11.3 Amneal Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Amneal Main Business Overview
12.11.5 Amneal Latest Developments
12.12 Marksans Pharma
12.12.1 Marksans Pharma Company Information
12.12.2 Marksans Pharma Gabapentin Product Offered
12.12.3 Marksans Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Marksans Pharma Main Business Overview
12.12.5 Marksans Pharma Latest Developments
12.13 Glenmark
12.13.1 Glenmark Company Information
12.13.2 Glenmark Gabapentin Product Offered
12.13.3 Glenmark Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Glenmark Main Business Overview
12.13.5 Glenmark Latest Developments
12.14 Alkem
12.14.1 Alkem Company Information
12.14.2 Alkem Gabapentin Product Offered
12.14.3 Alkem Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Alkem Main Business Overview
12.14.5 Alkem Latest Developments
12.15 Jiangsu Enhua
12.15.1 Jiangsu Enhua Company Information
12.15.2 Jiangsu Enhua Gabapentin Product Offered
12.15.3 Jiangsu Enhua Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Jiangsu Enhua Main Business Overview
12.15.5 Jiangsu Enhua Latest Developments
12.16 Jiangsu Hengrui
12.16.1 Jiangsu Hengrui Company Information
12.16.2 Jiangsu Hengrui Gabapentin Product Offered
12.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Jiangsu Hengrui Main Business Overview
12.16.5 Jiangsu Hengrui Latest Developments
12.17 Sailike
12.17.1 Sailike Company Information
12.17.2 Sailike Gabapentin Product Offered
12.17.3 Sailike Gabapentin Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Sailike Main Business Overview
12.17.5 Sailike Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Gabapentin Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Capsule
Table 3. Major Players of Tablet
Table 4. Global Gabapentin Sales by Type (2016-2021) & (K MT)
Table 5. Global Gabapentin Sales Market Share by Type (2016-2021)
Table 6. Global Gabapentin Revenue by Type (2016-2021) & ($ million)
Table 7. Global Gabapentin Revenue Market Share by Type (2016-2021)
Table 8. Global Gabapentin Sale Price by Type (2016-2021)
Table 9. Global Gabapentin Sales by Application (2016-2021) & (K MT)
Table 10. Global Gabapentin Sales Market Share by Application (2016-2021)
Table 11. Global Gabapentin Value by Application (2016-2021)
Table 12. Global Gabapentin Revenue Market Share by Application (2016-2021)
Table 13. Global Gabapentin Sale Price by Application (2016-2021)
Table 14. Global Gabapentin Sales by Company (2019-2021) & (K MT)
Table 15. Global Gabapentin Sales Market Share by Company (2019-2021)
Table 16. Global Gabapentin Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Gabapentin Revenue Market Share by Company (2019-2021)
Table 18. Global Gabapentin Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Gabapentin Producing Area Distribution and Sales Area
Table 20. Players Gabapentin Products Offered
Table 21. Gabapentin Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Gabapentin Sales by Region (2016-2021) (K MT)
Table 25. Global Gabapentin Sales Market Share by Region (2016-2021)
Table 26. Global Gabapentin Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Gabapentin Revenue Market Share by Region (2016-2021)
Table 28. Americas Gabapentin Sales by Country (2016-2021) & (K MT)
Table 29. Americas Gabapentin Sales Market Share by Country (2016-2021)
Table 30. Americas Gabapentin Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Gabapentin Revenue Market Share by Country (2016-2021)
Table 32. Americas Gabapentin Sales by Type (2016-2021) & (K MT)
Table 33. Americas Gabapentin Sales Market Share by Type (2016-2021)
Table 34. Americas Gabapentin Sales by Application (2016-2021) & (K MT)
Table 35. Americas Gabapentin Sales Market Share by Application (2016-2021)
Table 36. APAC Gabapentin Sales by Region (2016-2021) & (K MT)
Table 37. APAC Gabapentin Sales Market Share by Region (2016-2021)
Table 38. APAC Gabapentin Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Gabapentin Revenue Market Share by Region (2016-2021)
Table 40. APAC Gabapentin Sales by Type (2016-2021) & (K MT)
Table 41. APAC Gabapentin Sales Market Share by Type (2016-2021)
Table 42. APAC Gabapentin Sales by Application (2016-2021) & (K MT)
Table 43. APAC Gabapentin Sales Market Share by Application (2016-2021)
Table 44. Europe Gabapentin Sales by Country (2016-2021) & (K MT)
Table 45. Europe Gabapentin Sales Market Share by Country (2016-2021)
Table 46. Europe Gabapentin Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Gabapentin Revenue Market Share by Country (2016-2021)
Table 48. Europe Gabapentin Sales by Type (2016-2021) & (K MT)
Table 49. Europe Gabapentin Sales Market Share by Type (2016-2021)
Table 50. Europe Gabapentin Sales by Application (2016-2021) & (K MT)
Table 51. Europe Gabapentin Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Gabapentin Sales by Country (2016-2021) & (K MT)
Table 53. Middle East & Africa Gabapentin Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Gabapentin Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Gabapentin Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Gabapentin Sales by Type (2016-2021) & (K MT)
Table 57. Middle East & Africa Gabapentin Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Gabapentin Sales by Application (2016-2021) & (K MT)
Table 59. Middle East & Africa Gabapentin Sales Market Share by Application (2016-2021)
Table 60. Global Gabapentin Sales Forecast by Type (2021-2026) & (K MT)
Table 61. Global Gabapentin Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Gabapentin Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Gabapentin Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Gabapentin Sales Forecast by Application (2021-2026) & (K MT)
Table 65. Global Gabapentin Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Gabapentin Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Gabapentin Revenue Market Share Forecast by Application (2021-2026)
Table 68. Pfizer Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 69. Pfizer Gabapentin Product Offered
Table 70. Pfizer Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 71. Pfizer Main Business
Table 72. Pfizer Latest Developments
Table 73. Assertio Therapeutics Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 74. Assertio Therapeutics Gabapentin Product Offered
Table 75. Assertio Therapeutics Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 76. Assertio Therapeutics Main Business
Table 77. Assertio Therapeutics Latest Developments
Table 78. TEVA Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 79. TEVA Gabapentin Product Offered
Table 80. TEVA Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 81. TEVA Main Business
Table 82. TEVA Latest Developments
Table 83. Mylan Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 84. Mylan Gabapentin Product Offered
Table 85. Mylan Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 86. Mylan Main Business
Table 87. Mylan Latest Developments
Table 88. Arbor Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 89. Arbor Pharma Gabapentin Product Offered
Table 90. Arbor Pharma Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 91. Arbor Pharma Main Business
Table 92. Arbor Pharma Latest Developments
Table 93. Novartis Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Gabapentin Product Offered
Table 95. Novartis Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
Table 98. Apotex Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 99. Apotex Gabapentin Product Offered
Table 100. Apotex Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 101. Apotex Main Business
Table 102. Apotex Latest Developments
Table 103. Sun Pharmaceutical Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 104. Sun Pharmaceutical Gabapentin Product Offered
Table 105. Sun Pharmaceutical Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 106. Sun Pharmaceutical Main Business
Table 107. Sun Pharmaceutical Latest Developments
Table 108. Aurobindo Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 109. Aurobindo Pharma Gabapentin Product Offered
Table 110. Aurobindo Pharma Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 111. Aurobindo Pharma Main Business
Table 112. Aurobindo Pharma Latest Developments
Table 113. Intas Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 114. Intas Gabapentin Product Offered
Table 115. Intas Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 116. Intas Main Business
Table 117. Intas Latest Developments
Table 118. Amneal Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 119. Amneal Gabapentin Product Offered
Table 120. Amneal Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 121. Amneal Main Business
Table 122. Amneal Latest Developments
Table 123. Marksans Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 124. Marksans Pharma Gabapentin Product Offered
Table 125. Marksans Pharma Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 126. Marksans Pharma Main Business
Table 127. Marksans Pharma Latest Developments
Table 128. Glenmark Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 129. Glenmark Gabapentin Product Offered
Table 130. Glenmark Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 131. Glenmark Main Business
Table 132. Glenmark Latest Developments
Table 133. Alkem Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 134. Alkem Gabapentin Product Offered
Table 135. Alkem Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 136. Alkem Main Business
Table 137. Alkem Latest Developments
Table 138. Jiangsu Enhua Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 139. Jiangsu Enhua Gabapentin Product Offered
Table 140. Jiangsu Enhua Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 141. Jiangsu Enhua Main Business
Table 142. Jiangsu Enhua Latest Developments
Table 143. Jiangsu Hengrui Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 144. Jiangsu Hengrui Gabapentin Product Offered
Table 145. Jiangsu Hengrui Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 146. Jiangsu Hengrui Main Business
Table 147. Jiangsu Hengrui Latest Developments
Table 148. Sailike Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 149. Sailike Gabapentin Product Offered
Table 150. Sailike Gabapentin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 151. Sailike Main Business
Table 152. Sailike Latest Developments
List of Figures
Figure 1. Picture of Gabapentin
Figure 2. Gabapentin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gabapentin Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Gabapentin Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Gabapentin Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Capsule
Figure 10. Product Picture of Tablet
Figure 11. Global Gabapentin Sales Market Share by Type in 2020
Figure 12. Global Gabapentin Revenue Market Share by Type (2016-2021)
Figure 13. Gabapentin Consumed in Epilepsy
Figure 14. Global Gabapentin Market: Epilepsy (2016-2021) & (K MT)
Figure 15. Gabapentin Consumed in Neuropathic Pain
Figure 16. Global Gabapentin Market: Neuropathic Pain (2016-2021) & (K MT)
Figure 17. Gabapentin Consumed in Restless Legs Syndrome
Figure 18. Global Gabapentin Market: Restless Legs Syndrome (2016-2021) & (K MT)
Figure 19. Gabapentin Consumed in Others
Figure 20. Global Gabapentin Market: Others (2016-2021) & (K MT)
Figure 21. Global Gabapentin Sales Market Share by Application (2016-2021)
Figure 22. Global Gabapentin Revenue Market Share by Application in 2020
Figure 23. Global Gabapentin Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Gabapentin Revenue Market Share by Company in 2020
Figure 25. Global Gabapentin Sales Market Share by Regions (2016-2021)
Figure 26. Global Gabapentin Revenue Market Share by Region in 2020
Figure 27. Americas Gabapentin Sales 2016-2021 (K MT)
Figure 28. Americas Gabapentin Revenue 2016-2021 ($ Millions)
Figure 29. APAC Gabapentin Sales 2016-2021 (K MT)
Figure 30. APAC Gabapentin Revenue 2016-2021 ($ Millions)
Figure 31. Europe Gabapentin Sales 2016-2021 (K MT)
Figure 32. Europe Gabapentin Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Gabapentin Sales 2016-2021 (K MT)
Figure 34. Middle East & Africa Gabapentin Revenue 2016-2021 ($ Millions)
Figure 35. Americas Gabapentin Sales Market Share by Country in 2020
Figure 36. Americas Gabapentin Revenue Market Share by Country in 2020
Figure 37. Americas Gabapentin Sales Market Share by Type in 2020
Figure 38. Americas Gabapentin Sales Market Share by Application in 2020
Figure 39. United States Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Gabapentin Sales Market Share by Region in 2020
Figure 44. APAC Gabapentin Revenue Market Share by Regions in 2020
Figure 45. APAC Gabapentin Sales Market Share by Type in 2020
Figure 46. APAC Gabapentin Sales Market Share by Application in 2020
Figure 47. China Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Gabapentin Sales Market Share by Country in 2020
Figure 54. Europe Gabapentin Revenue Market Share by Country in 2020
Figure 55. Europe Gabapentin Sales Market Share by Type in 2020
Figure 56. Europe Gabapentin Sales Market Share by Application in 2020
Figure 57. Germany Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Gabapentin Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Gabapentin Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Gabapentin Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Gabapentin Sales Market Share by Application in 2020
Figure 66. Egypt Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Gabapentin Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles